National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2014 (No. 5) (PB 41 of 2014) (Cth)

PB 41 of 2014

National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2014 (No. 5)

National Health Act 1953

___________________________________________________________________________

I, Kim Bessell, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.

Dated  15 May 2014

KIM BESSELL

Assistant Secretary

Pharmaceutical Access Branch

Principal Pharmacy Advisor  

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________

1              Name of Instrument

(1)This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2014 (No.5).

(2)This Instrument may also be cited as PB 41 of 2014.

2             Commencement

This Instrument commences on 1 June 2014.

3              Amendments to PB 79 of 2011

Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).

Schedule 1                   Amendments

1. Schedule 1 Part 1, entry for Epirubicin in the form ‘Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL’ with manner of administration Injection/Intravesical:

omit from the column headed ‘Brand’: Eprirubicin Actavis 100   substitute: Epirubicin ACT

omit from the column headed ‘Responsible Person’: TA   substitute: VN

1. Schedule 3, Responsible Person codes, after entry for TX:

insert:

VN Actavis Australia Pty Ltd  43 122 896 468